Anika Therapeutics, Inc. (NASDAQ:ANIK)
CAPS Rating:
The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
Recs
A stock my pet formula says is worth more than it's 52 week high, and has 18% insider ownership is something I have to five a green thumb to, never mind the currently crappy charts.